Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study
Petersen NH, Kodali S, Meng C, Li F, Nguyen CK, Peshwe KU, Strander S, Silverman A, Kimmel A, Wang A, Anadani M, Almallouhi E, Spiotta AM, Kim JT, Giles JA, Keyrouz SG, Farooqui M, Zevallos C, Maier IL, Psychogios MN, Liman J, Riou-Comte N, Richard S, Gory B, Wolfe S, Brown PA, Fargen KM, Mistry EA, Fakhri H, Mistry AM, Wong KH, de Havenon A, Nascimento FA, Kan P, Matouk C, Ortega-Gutiérrez S, Sheth KN. Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study. Stroke 2021, 53: 1216-1225. PMID: 34781705, PMCID: PMC8960326, DOI: 10.1161/strokeaha.121.034408.Peer-Reviewed Original ResearchConceptsSymptomatic intracranial hemorrhageEndovascular thrombectomyBlood pressure trajectoriesFunctional outcomeHemorrhagic transformationIschemic strokeSBP trajectoriesIntracranial hemorrhageAnterior circulation large vessel occlusion ischemic strokeModified Rankin Scale (mRS) 90 daysTrajectory groupsLarge vessel occlusion ischemic strokeMulticenter retrospective cohort studySystolic blood pressure trajectoriesBlood pressure courseOptimal hemodynamic managementSBP trajectory groupsRetrospective cohort studyAcute ischemic strokeElevated blood pressurePoor functional outcomePressure trajectoriesBlood pressure dataCohort studySecondary outcomesEndovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke
Hutchinson M, Beslow L, Shih E, Licht D, Kimmel A, Granath C, Ichord R. Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke. European Journal Of Paediatric Neurology 2021, 34: 99-104. PMID: 34454335, DOI: 10.1016/j.ejpn.2021.08.004.Peer-Reviewed Original ResearchConceptsAcute ischemic strokeLarge vessel occlusionEndovascular therapyHyperacute therapyIV-tPAVessel occlusionIschemic strokeMedical contraindicationsScore 6Childhood arterial ischemic strokeIntravenous tissue plasminogen activatorNIH Stroke Scale scoreArterial ischemic strokeStroke Scale scoreSingle-center cohortMild neurologic deficitsTime of presentationComplete vessel occlusionTissue plasminogen activatorChildren ages 2Hyperacute treatmentClinical characteristicsNeurologic deficitsStroke pathwayTreatment eligibility